---
layout: post
title: "Antimicrobial Susceptibility Test System Devices-Updating Breakpoints in Device Labeling; Guidance for Industry; Availability"
date: 2026-02-05 18:57:02 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-21407
original_published: 2023-09-29 00:00:00 +0000
significance: 8.00
---

# Antimicrobial Susceptibility Test System Devices-Updating Breakpoints in Device Labeling; Guidance for Industry; Availability

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** September 29, 2023 00:00 UTC
**Document Number:** 2023-21407

## Summary

The Food and Drug Administration (FDA or we) is announcing the availability of a final guidance for industry and FDA staff entitled "Antimicrobial Susceptibility Test (AST) System Devices--Updating Breakpoints in Device Labeling." This guidance is intended to provide industry and FDA staff with information regarding updating susceptibility test interpretative criteria (STIC)/breakpoints and associated performance data in device labeling for antimicrobial susceptibility test (AST) system devices in response to breakpoint changes posted on the FDA-Recognized Antimicrobial Susceptibility Test Interpretative Criteria website (STIC website). This guidance is expected to facilitate the timely adoption of updated breakpoints in AST system devices, which helps to ensure device safety and effectiveness.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/09/29/2023-21407/antimicrobial-susceptibility-test-system-devices-updating-breakpoints-in-device-labeling-guidance)
- API: https://www.federalregister.gov/api/v1/documents/2023-21407

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
